Remove 2023 Remove Healthcare Remove Prescription
article thumbnail

Why script-to-dispense conversion will take centre stage in 2023

pharmaphorum

In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. The account carried an official blue check mark, but in fact it did not belong to the prescription drugmaker. in 1979 to 2.8%in Ensuring patient access.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way.

article thumbnail

AbbVie sucks

World of DTC Marketing

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The executives at AbbVie make over $300 million.

article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). And in 2023, these investments will hopefully pay off. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 105
article thumbnail

Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market

Nixon Gwilt Law

As a law firm focused specifically on healthcare innovation, we get really excited about developing areas of the healthcare industry. Digital health companies building VR solutions often ask us this question, and if you are a founder or executive looking for ways to commercialize your VR platform for healthcare providers in the U.S.,

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records.